The weekly litigation news digest is live. Subscribe now

IP Verse

Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease - EP3009143

The patent EP3009143 was granted to Neurodyn Life Sciences on Oct 3, 2018. The application was filed on Jan 16, 2009 under application number EP15194111A. The patent is currently recorded with a legal status of "Revoked".

EP3009143

NEURODYN LIFE SCIENCES
Application Number
EP15194111A
Filing Date
Jan 16, 2009
Status
Revoked
Jul 7, 2023
Publication Date
Oct 3, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
CMS CAMERON MCKENNA NABARRO OLSWANGJul 3, 2019CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE
MATHYS & SQUIREJul 2, 2019WILDINGADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006252705
DESCRIPTIONUS4713249
DESCRIPTIONUS5266333
DESCRIPTIONUS5417982
DESCRIPTIONUS6333194
DESCRIPTIONUS7105342
DESCRIPTIONUS7112668
OPPOSITIONEP2687223
OPPOSITIONUS2005123962
OPPOSITIONWO2007146046
OPPOSITIONWO2008019187
OPPOSITIONWO2008079187
OPPOSITIONWO2009010045
SEARCHWO2007146046
SEARCHWO2008019187
SEARCHWO2009010045

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents